Literature DB >> 7888209

Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.

C Bruce1, C Clegg, A Featherstone, J Smith, B Biryahawaho, R Downing, J Oram.   

Abstract

DNA sequences encoding the C2-V3 regions or the C2-V5 regions of the surface glycoprotein gp120 of the human immunodeficiency virus type 1 (HIV-1) were amplified by the polymerase chain reaction (PCR) from peripheral blood mononuclear cells obtained in 1990/1992 from 20 infected Ugandans. The PCR-amplified DNA was cloned into a phagemid vector and between 1 and 12 clones from each provirus were sequenced. The Ugandan proviruses were aligned into four subtypes (A, B, C, and D) by phylogenetic analysis of consensus nucleotide sequences for the C2-V3 regions. Analysis of the deduced amino acid sequences of the C2-V3 regions by a maximum parsimony program gave a similar phylogenetic relationship. The data indicated that phylogenetic analysis of nucleotide and/or amino acid sequences from the C2-V3 regions is a reliable method of subtype determination. The consensus amino acid sequence of the subtype A and D proviruses were almost identical to those of the Albert et al. group B and group A proviruses, respectively. The deduced amino acid sequences of the C2-V5 regions of six of these proviruses showed considerable diversity both between patients and within patients. The region varied in length between 234 and 243 amino acids and included deletions and repetitions, particularly in the V4 region.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Genetic Technics; Hiv; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Physiology; Research Report; Uganda; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 7888209     DOI: 10.1089/aid.1994.10.1543

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.

Authors:  K Sherefa; M Sällberg; B Johansson; M Salminen; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.

Authors:  Banson Barugahare; Chris Baker; Okumu K'Aluoch; Richard Donovan; Mohamed Elrefaei; Mark Eggena; Norman Jones; Steven Mutalya; Cissy Kityo; Peter Mugyenyi; Huyen Cao
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Multivariate analysis of human immunodeficiency virus type 1 neutralization data.

Authors:  P N Nyambi; J Nkengasong; P Lewi; K Andries; W Janssens; K Fransen; L Heyndrickx; P Piot; G van der Groen
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.

Authors:  L G Kostrikis; Y Cao; H Ngai; J P Moore; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.

Authors:  L G Kostrikis; E Bagdades; Y Cao; L Zhang; D Dimitriou; D D Ho
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Predominance of HIV-1 subtype A and D infections in Uganda.

Authors:  D J Hu; J Baggs; R G Downing; D Pieniazek; J Dorn; C Fridlund; B Biryahwaho; S D Sempala; M A Rayfield; T J Dondero; R Lal
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.